Funder: National Institutes of Health
Due Dates: July 2, 2025 (Earliest Submission) | August 1, 2025 (Application Due)
Funding Amounts: Up to $125,000 direct costs/year for up to 5 years; typical total per award up to $625,000 direct costs.
Summary: Supports high-priority, regionally relevant infectious diseases research by international investigators in resource-constrained (non-U.S.) countries.
Key Information: Only non-U.S. institutions in low-, lower-middle-, or upper-middle-income countries (per World Bank) are eligible; clinical trials are not allowed.